S Jordan Kerns

USPTO Granted Patents = 24 (Patent Applications = 11)

CIPO Patents = 4 (Patent Applications = 8)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 7.4

ph-index = 2

Forward Citations = 15(Granted Patents)

Company Filing History:

Cedars-sinai Medical Center

patents

where one patent can have more than one assignee

Years Active: 2020-2025

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12378528 - Systems and methods for growth of intestinal cells in microfluidic devices (2025-08-05),

2. 12378519 - Microfluidic model of the blood brain barrier (2025-08-05),

3. 12298320 - Compound distribution in microfluidic devices (2025-05-13),

4. 12091650 - Development of spinal cord on a microfluidic chip (2024-09-17),

5. 12019083 - Compound distribution in microfluidic devices (2024-06-25),

6. 11952592 - Systems and methods for growth of intestinal cells in microfluidic devices (2024-04-09),

7. 11859165 - Open-top microfluidic device with structural anchors (2024-01-02),

8. 11833512 - In vitro epithelial models comprising lamina propria-derived cells (2023-12-05),

9. 11788044 - Rheologically biomimetic fluid surrogate (2023-10-17),

10. 11733234 - Compositions and methods of cell attachment (2023-08-22),

11. 11549937 - Compositions and methods of cell attachment (2023-01-10),

12. 11536714 - Compositions and methods of cell attachment (2022-12-27),

13. 11519903 - Compositions and methods of cell attachment (2022-12-06),

14. 11506653 - Compositions and methods of cell attachment (2022-11-22),

15. 11506652 - Compositions and methods of cell attachment (2022-11-22),

Title: S Jordan Kerns: Innovator in Microfluidics and Cellular Culture Technologies

Introduction

S Jordan Kerns, based in Reading, MA, is a prominent inventor with a notable portfolio comprising 21 patents. His work primarily focuses on the development of microfluidic technologies and their applications in culturing cells, with profound implications for medical research and treatment methodologies.

Latest Patents

Among Kerns's latest inventions is the "Development of Spinal Cord on a Microfluidic Chip," which enhances the ability to culture brain endothelial cells, and potentially astrocytes and neurons. This innovative approach allows cells to replicate the structure and functionality of the blood-brain barrier, significantly advancing beyond existing systems in terms of cell maturation and differentiation. Another significant patent is for "Compound Distribution in Microfluidic Devices." This invention addresses the challenge of molecule and compound absorbency in laboratory equipment while ensuring that gas transport within microfluidic devices is not unduly restricted. Both patents reflect Kerns's commitment to overcoming critical challenges in biotechnological applications.

Career Highlights

Throughout his career, Kerns has made significant contributions while working with reputable companies, including Emulate, Inc. and Cedars-Sinai Medical Center. His work in these organizations has played a crucial role in advancing the medical and research fields through innovative microfluidic solutions.

Collaborations

Kerns has collaborated with talented professionals such as Daniel Levner and Antonio Varone. These partnerships have facilitated the exchange of ideas and expertise, enhancing the impact of his innovations in the field of microfluidics.

Conclusion

S Jordan Kerns stands out as a leading inventor in the realm of microfluidic technologies and cellular culture. His groundbreaking patents and collaborative efforts position him at the forefront of research and innovation, contributing significantly to the scientific community's understanding and application of cell culture systems.

This text is generated by artificial intelligence and may not be accurate.